Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia
- 1 September 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 381 (2-3) , 113-119
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Synergistic Effects of a Combination of Low-Dose Basic Fibroblast Growth Factor and Citicoline After Temporary Experimental Focal IschemiaStroke, 1999
- Synergistic Effects of Citicoline and MK-801 in Temporary Experimental Focal Ischemia in RatsStroke, 1997
- Neuroprotective Effect of YM90K, a Novel AMPA/Kainate Receptor Antagonist, in Focal Cerebral Ischemia in CatsJournal of Cerebral Blood Flow & Metabolism, 1996
- Emerging treatments for stroke in humansTrends in Pharmacological Sciences, 1996
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist.Stroke, 1994
- Efficacy of d-CPPene, a competitive N-methyl-d-aspartate antagonist in focal cerebral ischemia in the ratNeuroscience Letters, 1992
- Combined treatment with MK-801 and nicardipine reduces global ischemic damage in the gerbil.Stroke, 1992
- Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion.Stroke, 1990
- The N-methyl-d-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbilsBrain Research, 1988